IL-6 plays a crucial role in the shift from mild inflammation to severe hyperinflammatory conditions, including cytokine release syndrome (CRS), acute respiratory distress syndrome (ARDS), and lung damage, which can lead to high mortality in critically ill COVID-19 patients [40]. This evidence concerns the gene IL6 and congenital rubella syndrome.